Description: Clevidipine HCl is a novel, potent and short acting, dihydropyridine-based L-type calcium channel blocker, which is highly selective for vascular, as opposed to myocardial, smooth muscle and, therefore, has little or no effect on myocardial contractility or cardiac conduction. It is uses as an antihypertensive agent for the reduction of blood pressure. It reduces mean arterial blood pressure by decreasing systemic vascular resistance. Clevidipine does not reduce cardiac filling pressure, confirming lack of effects on the venous capacitance vessels.

References: J Pediatr Pharmacol Ther. 2015 Jan-Feb;20(1):54-60.

纯度：≥98%